Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...

CHICAGO, APRIL 25, 2025 ― Researchers from The University of Texas MD Anderson Cancer Center will present promising results from clinical trials in three minisymposia abstracts at the American ...

The University of Texas MD Anderson Cancer Center has launched the Institute for Cell Therapy Discovery and Innovation, a research center that will focus on immunology and cell engineering with the ...

HOUSTON ― The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical ...

With more than $80 million in hand, the University of Texas MD Anderson Cancer Center has launched its own cell therapy institute. Dubbed the Institute for Cell Therapy Discovery & Innovation, the ...

At The University of Texas MD Anderson Cancer Center, our mission has always been clear: to end cancer. Achieving this goal requires more than just groundbreaking research and exceptional patient care ...

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD ...

The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and ...

This story is brought to you by Ochsner Health. The partnership between Ochsner Health and MD Anderson Cancer Center continues to gain momentum. Now, more cancer patients throughout South Louisiana ...

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS' AI-powered analytics with MD Anderson's clinical and ...